Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION

v3.8.0.1
STOCK-BASED COMPENSATION
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
NOTE D - STOCK-BASED COMPENSATION

Restricted Stock Units

 

During the nine months ended September 30, 2017, the Company issued 13,500 restricted stock units to each of its three non-management directors as an annual grant for 2017 for service on the Company's Board of Directors.  Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.  The restricted stock units vest in four equal quarterly installments of 3,375 shares of common stock on March 15, 2017, June 15, 2017, September 15, 2017 and December 15, 2017, subject to continued service on the Board of Directors.

 

A summary of restricted stock unit activity for the nine months ended September 30, 2017 is as follows (each restricted stock unit represents the right to receive one share of the Company's common stock):

 

    Number of Shares     Weighted-Average Grant Date Fair Value  
Balance of restricted stock units outstanding at December 31, 2016     890,000     $ 2.29  
Grants of restricted stock units     40,500     $ 3.80  
Vested restricted stock units     (100,375 )   $ (2.87 )
                 
Balance of unvested restricted stock units at September 30, 2017     830,125     $ 2.30  

 

Restricted stock unit compensation expense was $237,000 and $711,000 for the three and nine months ended September 30, 2017, respectively.  Restricted stock unit compensation expense was $189,000 and $221,000 for the three and nine months ended September 30, 2016, respectively.

 

The Company has an aggregate of $1,097,000 of unrecognized restricted stock unit compensation expense as of September 30, 2017 to be expensed over a weighted average period of 1.6 years.

 

All of the Company's 830,125 outstanding restricted stock units at September 30, 2017 have dividend equivalent rights.

 

Stock Options

 

There were no stock option grants during the three or nine months ended September 30, 2017 and September 30, 2016.

 

The following table presents information relating to all stock options outstanding and exercisable at September 30, 2017:

 

            Weighted    
        Weighted   Average    
Range of       Average   Remaining    
Exercise   Options   Exercise   Life in   Options
Price   Outstanding   Price   Years   Exercisable
                 
$0.83 - $2.34   2,110,000   $1.28   2.25   2,110,000

 

 

The Company had no recorded stock-based compensation related to stock option grants for the three months ended September 30, 2017 and September 30, 2016, respectively.  The Company recorded stock-based compensation related to stock option grants of $-0- and $12,000 for the nine months ended September 30, 2017 and September 30, 2016, respectively.

 

The Company had no unrecognized stock-based compensation cost as of September 30, 2017.  The aggregate intrinsic value of options exercisable at September 30, 2017 was $5,431,000.

 

During the nine months ended September 30, 2017, the Company's Chief Financial Officer and three of his children exercised stock options to purchase an aggregate of 75,000 shares of the Company's common stock at an exercise price of $1.40 per share.  In addition, during the nine months ended September 30, 2017, a former director exercised a stock option to purchase 125,000 shares of the Company's common stock at an exercise price of $1.40 per share.

 

Warrants

 

As of September 30, 2017, there were no outstanding warrants to purchase shares of the Company's common stock.

 

During the nine months ended September 30, 2017, Recognition Interface, LLC exercised its remaining warrants to purchase an aggregate of 375,000 shares of the Company's common stock, at an exercise price of $2.10 per share, which resulted in gross proceeds to the Company of $787,500.